众赢国际版app - Home - Annals of Pancreatic Cancer

AME and Wolters Kluwer aim to expand access to global medical research through new collaboration

The agreement broadens the reach of nearly 50 Open Access titles, contributing globally to over 5,000 articles

October 2, 2025 — Wolters Kluwer Health announced a new collaboration with AME Publishing Company, an Open Access publisher specializing in medical journals and books, headquartered in Hong Kong, China VSports app下载. .

Annals of Pancreatic Cancer 2024 CiteScore Released: 0.4

We are pleased to announce that the Annals of Pancreatic Cancer (APC) has achieved its 2024 CiteScore: 0 V体育官网. 4. APC ranks as follows across various categories: 151 out of 171 in Internal Medicine, 372 out of 415 in Oncology, 124 out of 130 in Endocrinology, and 225 out of 247 in Endocrinology, Diabetes and Metabolism. This milestone underscores our ongoing commitment to publishing impactful research in the field.

"V体育安卓版" Reviewer of the Month (2025)

In 2025, APC reviewers continue to make outstanding contributions to the peer review process VSports手机版. They demonstrated professional effort and enthusiasm in their reviews and provided comments that genuinely help the authors to enhance their work.

Hereby, we would like to highlight some of our outstanding reviewers, with a brief interview of their thoughts and insights as a reviewer V体育安卓版. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process.

Genetic alterations in the neuronal development genes are associated with changes of the tumor immune microenvironment in pancreatic cancer

Except for PTPRM and NBEA, genetic alterations involving these 20 genes are associated with significant changes in the densities of major immune cell subtypes. Except for AJAP1, the copy number loss involving this panel of neuronal development genes is significantly associated with changes in immune cell infiltrates V体育ios版. In contrast, the copy number gain in fewer genes, including NRXN3, ZNF667, ACSM3, C6, ADCY5, SCN9A, and PRKCE, is significantly associated with changes in immune cell infiltrates.

Painful tongue lesion as an initial presentation of metastatic pancreatic ductal adenocarcinoma: a case report and review of the literature

This report presents a unique case of a 91-year-old man who initially presented with a painful tongue mass and ultimately was found to have metastatic pancreatic ductal adenocarcinoma. Comparison of a biopsy from the tongue mass and the pancreatic lesion showed they were morphologically identical and confirmed the diagnosis. Treatment of the tongue lesion with palliative radiation led to clinical improvement of difficulty and pain with swallowing VSports最新版本.

Association of a genetic variant in the adenosine triphosphate transmembrane glycoprotein and risk of pancreatic cancer

In the current study, there was no significant difference between rs1045642 and sufentanil consumption (P>0. 05), while previous investigation showed a positive association between the variation and PC. Pang et al V体育平台登录. , in 2014, investigated the potential relationship between the progression of PC and chemical resistance. In this study, 4 SNPs in different genes, including ABCB1, and the expression of 3 transporters were investigated in healthy and cancerous samples.

Why do we need a journal solely focused on the malignant diseases of the pancreas?

Pancreatic cancer has become the third leading cause of death from malignant diseases in both the United States and Europe. The incidence of pancreatic cancer is rising VSports注册入口. Tremendous efforts have been devoted to basic and clinical research in pancreatic cancer. However, the outcome of pancreatic cancer has been minimally improved over the last thirty years. Such a profound sadness tells us that we should spend more efforts and be more focused on this disease. There had been no scientific journal that is solely focused on the malignant diseases of the pancreas. It is critical to have a media to rapidly disseminate research news and reports within the communities of pancreatic cancer researchers and have a venue to discuss the management strategies for pancreatic cancer among clinicians. This is why we are launching Annals of Pancreatic Cancer.

‹ ›

Articles in Press

Past Issues

About apc

Manuscript Submission

AME Editing Service

V体育官网 - Reprint & Permission

Advertising (VSports)

Contact us

General editorial enquiries:
"VSports app下载" Email: apc@www.qiuluzeuv.cn
Copyright related contact:
Email: permissions@www.qiuluzeuv.cn
Commercial Sales contact (Reprints, advertising, etc.):
V体育官网入口 - Email: sales@www.qiuluzeuv.cn

Original Article

Efficacy and toxicity of gemcitabine plus nab-paclitaxel in patients with metastatic pancreatic adenocarcinoma after disease progression on FOLFIRINOX: a single-center analysis

Marcos Pedro Guedes Camandaroba, Francisco de Assis Maia Jr, Cícero Gonzaga Santos, Tiago Cordeiro Felismino, Victor Hugo Fonseca de Jesus

Annals of Pancreatic Cancer

2025;

(30 September 2025)

PDF Full Text (720) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Editorial Commentary

Another chapter in the tale of FOLFIRINOX in the management of pancreatic ductal adenocarcinoma: do the results in the locally advanced setting fall short of expectations?

Victor Hugo Fonseca de Jesus

Annals of Pancreatic Cancer

2025;

(30 September 2025)

PDF Full Text (458) Peer Review File COI Form Open Access

Brief Report

Concordance between preoperative imaging and surgical specimen size in the evaluation of intraductal papillary mucinous neoplasms of the pancreas

Juan P. Cobar, Amir Ebadinejad, Elsayed Ibrahim, Julia Silverman, Tony El-Jabbour, David O’Sullivan, Lindsay Bliss, David Curtis, Bret Schipper, Saverio Ligato, Oscar K. Serrano

Annals of Pancreatic Cancer

2025;

(30 August 2025)

PDF Full Text (284) Data Sharing Statement Peer Review File COI Form Open Access

Letter to the Editor

Cabozantinib in well-differentiated metastatic pancreatic neuroendocrine tumors: a promising addition to the therapeutic arsenal

Syeda Samia Fatima, Hamdia Gul Aslam, Sarah Zaka, Syeda Faiqa Imran

Annals of Pancreatic Cancer

2025;

(30 August 2025)

PDF Full Text (388) Peer Review File COI Form Open Access

Original Article

Exploring the link between pancreatic cancer and key risk factors: insights from decade-long study in Eastern Algeria

Imene Hamiouda, Brahim Djoudi, Rania Laouar, Hadia Ziada, Youcef Khenchoul, Karima Sifi, Norreddine Abadi, Dalila Satta

Annals of Pancreatic Cancer

2025;

(30 July 2025)

PDF Full Text (610) Data Sharing Statement Peer Review File COI Form Open Access

Original Article

FOLFIRINOX versus gemcitabine (plus paclitaxel) for pancreatic cancer—an analysis based on data from the Clinical Cancer Registry of Lower Saxony

Jonathan Engelke, Mike Klora, Jan Zeidler, Tonia Brand

Annals of Pancreatic Cancer

2025;

(30 July 2025)

PDF Full Text (991) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Original Article

Treatment and prophylaxis of thromboembolism in pancreatic cancer: influence on patient survival in western Algeria

Hakima Kehili, Aicha Bengueddach, Naouel Fatima Zohra Boumansour, Wefa Boughrara, Faiza Bereksi-Reguig

Annals of Pancreatic Cancer

2025;

(30 July 2025)

PDF Full Text (457) Data Sharing Statement Peer Review File COI Form Open Access

Original Article

Identification and assessment of ferroptosis-related genes and their implication as therapeutic agents for pancreatic ductal adenocarcinoma

Syed Luqman Ali, Awais Ali, Asifullah Khan

Annals of Pancreatic Cancer

2025;

(30 July 2025)

PDF Full Text (512) Peer Review File COI Form Open Access

Case Series

Duodenal aspiration biopsy for diagnosing pancreatic cystic lesions: a four-case series

Aleksei Kashintsev, Vitali Proutski

Annals of Pancreatic Cancer

2025;

(30 July 2025)

PDF Full Text (510) Reporting Checklist Peer Review File COI Form Open Access

Review Article 

The role of alcohol as a risk factor in pancreatic cancer: a systematic review based on cohort and case-control studies

Hamed Delam, Maryam Roosta, Sara Moghaddam, Hossein Kargar Jahromi, Kosar Seidmohammadi, Hamed Safari

Annals of Pancreatic Cancer

2025;

(30 July 2025)

PDF Full Text (733) Reporting Checklist Peer Review File COI Form Open Access

Original Article

Combination of axial and bivalve techniques in the grossing protocol for pancreaticoduodenectomy specimens in the assessment of ampullary and pancreatic adenocarcinomas and intraductal papillary mucinous neoplasia

Judith González-López, Óscar Castells-Perona, Cecilia López-Valdivia, Roberto Díaz-Beveridge, Cristina Ballester-Ibáñez, Eva Montalvá-Orón, Rafael López-Andújar, Judith Pérez-Rojas

Annals of Pancreatic Cancer

2025;

(30 May 2025)

PDF Full Text (376) Data Sharing Statement Peer Review File COI Form Open Access

Case Report

Clear cell carcinoma of the pancreas: a case report of a not so clear disease

Cassidy Gawlik, Kathryn Stackhouse, Scott E. Kilpatrick

Annals of Pancreatic Cancer

2025;

(30 March 2025)

PDF Full Text (1223) Reporting Checklist Peer Review File COI Form Open Access

Review Article 

Bibliometric review of journal articles on pancreatic cancer: insights into productivity and impact

Christopher Wu, Julia Adriana Kasmirski, Raj Roy, Zhixing Song, Quince-Xhosa D. Gibson, Herbert Chen, J. Bart Rose, Andrea Gillis

Annals of Pancreatic Cancer

2025;

(30 March 2025)

PDF Full Text (1835) Reporting Checklist Peer Review File COI Form Open Access

Original Article

Synthesis and evaluation of novel pyrimidine derivative targeting pancreatic adenocarcinoma

Manjunatha Panduranga Mudgal, Madhu Mallapura Vijayakumar, Ravi Kumar Tiwari, Gurubasavaraja Swamy Purawarga Matada, Suresh Janadri, Uday Raj Sharma

Annals of Pancreatic Cancer

2024;

(31 October 2024)

PDF Full Text (1705) Data Sharing Statement Peer Review File COI Form Open Access

Original Article

Diagnostic precision of endoscopic ultrasound versus contrast-enhanced computed tomography in detection of vascular involvement in pancreatic and periampullary cancers as compared to surgery

Amr Abou-Elmagd, Mohamed Yousry Taher, Ahmed Zeid, Ahmed El-Gendi, Ahmed Sedky, Sameh Aldesoky Lashen

Annals of Pancreatic Cancer

2024;

(31 October 2024)

PDF Full Text (10788) Data Sharing Statement Peer Review File COI Form Open Access

Case Report

Visceral crisis in a patient with pancreatic ductal adenocarcinoma with DPYD and UGT1A1 gene mutations: case report, literature review, and viewpoint

Luxi Chen, Cynthia Mark, Matthew I. Ebia, Anser Abbas, David Oveisi, Suzanne Dotson, Jun Gong, Andrew Hendifar, Arsen Osipov

Annals of Pancreatic Cancer

2024;

(31 October 2024)

PDF Full Text (8944) Reporting Checklist Peer Review File COI Form Open Access

Original Article

Effects of treatment delays on outcomes in pancreatic adenocarcinoma

Calvin X. Geng, Anuragh R. Gudur, Laura B. Lavette, Ross C. D. Buerlein, Daniel S. Strand, Vanessa M. Shami, Andrew Y. Wang, Matthew J. Reilley, Alexander Podboy

Annals of Pancreatic Cancer

2024;

(30 September 2024)

PDF Full Text (11504) Peer Review File COI Form Open Access

Original Article

Probabilistic modelling of pancreatic cancer survival: can Markov chains predict survival in stage IV pancreatic cancer?

Josie Currie, Geoffrey Currie, Eric Rohren

Annals of Pancreatic Cancer

2024;

(31 August 2024)

PDF Full Text (9427) Data Sharing Statement Peer Review File COI Form Open Access

Original Article

The impact of KRAS mutations on the clinical outcome and immune response following immunotherapy for pancreatic cancer

Eric S. Christenson, Raymond Yu, Jessica Gai, Hao Wang, Ming Lei, Lei Zheng

Annals of Pancreatic Cancer

2024;

(30 June 2024)

PDF Full Text (3778) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Case Report

Resolution of a rare case of hypercalcemia in a PTHrp-producing pancreatic neuroendocrine tumor using selective internal radiation therapy with ⁹⁰Y microspheres

Elena Dobra Neacsu, Elena Martínez Montalbán, Bárbara Martínez de Miguel

Annals of Pancreatic Cancer

2024;

(30 June 2024)

PDF Full Text (9692) Peer Review File COI Form Open Access

View more articles

Currently no content available!

Abstract

AB091. P063. Case report: stage 4 pancreatic cancer to remission using paricalcitol and hydroxychloroquine in addition to traditional chemotherapy

Stephen Bigelsen

Published online: 23 April 2018

PDF ABSTRACT (18192) Open Access

Original Article

Modified FOLFIRINOX as the first-line chemotherapy in unresectable and metastatic pancreatic adenocarcinoma—a single-center experience in India

Satyajeet Soni, Arpit Jain, Varun Goyal, Satya Narayan, Pallavi Redhu, Pankaj Goyal, Shiva Shankara Swamy, Vineet Talwar

Published online: 15 November 2023

PDF Full Text (15641) Data Sharing Statement Peer Review File COI Form Open Access

Review Article 

Preclinical mouse models for immunotherapeutic and non-immunotherapeutic drug development for pancreatic ductal adenocarcinoma

Mengni He, MacKenzie Henderson, Stephen Muth, Adrian Murphy, Lei Zheng

Published online: 22 July 2020

PDF Full Text (14859) COI Form Open Access

Review Article 

Multifunctional role of pancreatic stellate cells in pancreatic cancer

Alpha R. Mekapogu, Srinivasa P. Pothula, Romano C. Pirola, Jeremy S. Wilson, Minoti V. Apte

Published online: 12 June 2019

PDF Full Text (12596) COI Form Open Access

Review Article 

Genetics and biology of pancreatic cancer and its precursor lesions: lessons learned from human pathology and mouse models

Motoyuki Tsuda, Akihisa Fukuda, Kyoichi Takaori, Hiroshi Seno

Published online: 22 August 2019

PDF Full Text (11746) COI Form Open Access

Original Article

Effects of treatment delays on outcomes in pancreatic adenocarcinoma

Calvin X. Geng, Anuragh R. Gudur, Laura B. Lavette, Ross C. D. Buerlein, Daniel S. Strand, Vanessa M. Shami, Andrew Y. Wang, Matthew J. Reilley, Alexander Podboy

Published online: 20 September 2024

PDF Full Text (11504) Peer Review File COI Form Open Access

Original Article

Diagnostic precision of endoscopic ultrasound versus contrast-enhanced computed tomography in detection of vascular involvement in pancreatic and periampullary cancers as compared to surgery

Amr Abou-Elmagd, Mohamed Yousry Taher, Ahmed Zeid, Ahmed El-Gendi, Ahmed Sedky, Sameh Aldesoky Lashen

Published online: 10 October 2024

PDF Full Text (10788) Data Sharing Statement Peer Review File COI Form Open Access

Review Article 

Cellular crosstalk mediating immune evasion in pancreatic cancer microenvironment

Chenggang Gao, Qiang Shen, Tao Yin

Published online: 19 July 2019

PDF Full Text (10457) COI Form Open Access

Foreword

Introduction of special column “Case Report/Precision Medicine”

Xu Che, Lei Zheng

Published online: 25 August 2020

PDF Pages: 11 Full Text (10281) COI Form Open Access

Case Report

Resolution of a rare case of hypercalcemia in a PTHrp-producing pancreatic neuroendocrine tumor using selective internal radiation therapy with ⁹⁰Y microspheres

Elena Dobra Neacsu, Elena Martínez Montalbán, Bárbara Martínez de Miguel

Published online: 13 June 2024

PDF Full Text (9692) Peer Review File COI Form Open Access

Original Article

Probabilistic modelling of pancreatic cancer survival: can Markov chains predict survival in stage IV pancreatic cancer?

Josie Currie, Geoffrey Currie, Eric Rohren

Published online: 05 August 2024

PDF Full Text (9427) Data Sharing Statement Peer Review File COI Form Open Access

Review Article 

Targeting the epigenome of pancreatic cancer for therapy: challenges and opportunities

Marina Baretti, Nita Ahuja, Nilofer Saba Azad

Published online: 23 October 2019

PDF Full Text (9362) COI Form Open Access

Review Article 

Ductal vs. acinar? Recent insights into identifying cell lineage of pancreatic ductal adenocarcinoma

Yi Xu, Jun Liu, Michael Nipper, Pei Wang

Published online: 17 June 2019

PDF Full Text (9240) COI Form Open Access

Case Report

Visceral crisis in a patient with pancreatic ductal adenocarcinoma with DPYD and UGT1A1 gene mutations: case report, literature review, and viewpoint

Luxi Chen, Cynthia Mark, Matthew I. Ebia, Anser Abbas, David Oveisi, Suzanne Dotson, Jun Gong, Andrew Hendifar, Arsen Osipov

Published online: 10 October 2024

PDF Full Text (8944) Reporting Checklist Peer Review File COI Form Open Access

Review Article 

Superior mesenteric artery-first approach with laparoscopic pancreaticoduodenectomy

Xu Sun, Jing Mao, Xiaofeng Ni, Qiang Yan

Published online: 19 August 2019

PDF Full Text (8158) COI Form Open Access

Review Article 

Adjuvant therapeutic strategies for resectable pancreatic adenocarcinoma

Nikhil Yegya-Raman, Mihir M. Shah, Miral S. Grandhi, Elizabeth Poplin, David A. August, Timothy J. Kennedy, Usha Malhotra, Kristen R. Spencer, Darren R. Carpizo, Salma K. Jabbour

Published online: 07 August 2018

PDF Full Text (7333) COI Form Open Access

Review Article 

Insights into the biology and treatment strategies of pancreatic neuroendocrine tumors

Jessica L. Buicko, Brendan M. Finnerty, Tiantian Zhang, Bu Jung Kim, Thomas J. Fahey III, Yi-Chieh Nancy Du

Published online: 20 June 2019

PDF Full Text (7328) COI Form Open Access

Review Article 

Malnutrition, frailty, and sarcopenia in pancreatic cancer patients: assessments and interventions for the pancreatic surgeon

Noah S. Rozich, Caitlin E. Jones, Katherine T. Morris

Published online: 11 March 2019

PDF Full Text (7259) COI Form Open Access

Review Article 

Altering the response to radiation: radiosensitizers and targeted therapies in pancreatic ductal adenocarcinoma: preclinical and emerging clinical evidence

Adam R. Wolfe, Terence M. Williams

Published online: 31 August 2018

PDF Full Text (7052) COI Form Open Access

Review Article 

Modeling human pancreatic ductal adenocarcinoma for translational research: current options, challenges, and prospective directions

Reecha Suri, Jacquelyn W. Zimmerman, Richard A. Burkhart

Published online: 29 December 2020

PDF Full Text (6996) COI Form Open Access

Full Most Read article list >>

Original Article

Quantitative metric for assessment of pancreatic ductal adenocarcinoma treatment response in T1-weighted gadolinium-enhanced magnetic resonance imaging

Joy Liau, Srinivasan Vedantham, Hani M. Babiker, Travis McGlothin, Diego R. Martin

Original Article

Nonselective β-adrenergic blockade impacts pancreatic cancer tumor biology, decreases perineural invasion and improves patient survival

Alex B. Blair, Noelle R. Jurcak, Ammar Javed, Jonathan Teinor, Vincent P. Groot, Noah Rozich, John L. Cameron, Matthew J. Weiss, Jin He, Christopher L. Wolfgang, Lei Zheng, Richard A. Burkhart

Original Article

Analyzing outcomes of neoadjuvant and adjuvant treatment for borderline-resectable pancreatic adenocarcinoma in the perioperative period at an academic institution

Alejandro Recio-Boiles, Jessica Vondrak, Summana Veeravelli, James J. Mancuso, Kathylynn Saboda, Denise J. Roe, Irbaz Bin Riaz, Aaron J. Scott, Emad Elquza, Ali McBride, Hani M. Babiker

Original Article

Adding combination immunotherapy consisting of cancer vaccine, anti-PD-1 and anti-CSF1R antibodies to gemcitabine improves anti-tumor efficacy in murine model of pancreatic ductal adenocarcinoma

May Tun Saung, Lei Zheng

Original Article

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios inversely correlate to clinical and pathologic stage in patients with resectable pancreatic ductal adenocarcinoma

Alejandro Recio-Boiles, Aparna Nallagangula, Summana Veeravelli, Jessica Vondrak, Kathylynn Saboda, Denise Roe, Emad Elquza, Ali McBride, Hani M. Babiker

Review Article 

Modeling human pancreatic ductal adenocarcinoma for translational research: current options, challenges, and prospective directions

Reecha Suri, Jacquelyn W. Zimmerman, Richard A. Burkhart

Review Article 

Preclinical mouse models for immunotherapeutic and non-immunotherapeutic drug development for pancreatic ductal adenocarcinoma

Mengni He, MacKenzie Henderson, Stephen Muth, Adrian Murphy, Lei Zheng

Review Article 

Targeting homologous recombination addicted tumors: challenges and opportunities

Talia Golan, Jonathan R. Brody

Review Article 

Evolving trends in pancreatic cancer therapeutic development

Imani Bijou, Jin Wang

Review Article 

Insights into the biology and treatment strategies of pancreatic neuroendocrine tumors

Jessica L. Buicko, Brendan M. Finnerty, Tiantian Zhang, Bu Jung Kim, Thomas J. Fahey III, Yi-Chieh Nancy Du

Review Article 

Ductal vs. acinar? Recent insights into identifying cell lineage of pancreatic ductal adenocarcinoma

Yi Xu, Jun Liu, Michael Nipper, Pei Wang

Review Article 

Malnutrition, frailty, and sarcopenia in pancreatic cancer patients: assessments and interventions for the pancreatic surgeon

Noah S. Rozich, Caitlin E. Jones, Katherine T. Morris

Review Article 

Altering the response to radiation: radiosensitizers and targeted therapies in pancreatic ductal adenocarcinoma: preclinical and emerging clinical evidence

Adam R. Wolfe, Terence M. Williams

Review Article 

Current and emerging radiotherapy strategies for pancreatic adenocarcinoma: stereotactic, intensity modulated and particle radiotherapy

Sweet Ping Ng, Eugene J. Koay

Review Article 

Adjuvant therapeutic strategies for resectable pancreatic adenocarcinoma

Nikhil Yegya-Raman, Mihir M. Shah, Miral S. Grandhi, Elizabeth Poplin, David A. August, Timothy J. Kennedy, Usha Malhotra, Kristen R. Spencer, Darren R. Carpizo, Salma K. Jabbour

Review Article 

Robotic distal pancreatectomy: greatest benefit for the frail?

Ioannis T. Konstantinidis, Laleh G. Melstrom

Editorial

Stressing for sugar: a new role of serotonin for glycolysis in pancreatic cancer cells

Gregory B. Lesinski

Editorial

Can computational modeling help in personalizing the care of patients with pancreatic ductal adenocarcinoma?

Efrat Dotan

Perspective 

Immune defects in pancreatic cancer

Lei Zheng

Journal Highlight more

Annals of Pancreatic Cancer is an international, open access, peer-reviewed journal for all researchers in the field of pancreatic cancer and for all health care providers who manage the care of pancreatic cancer patients, covering areas of basic biology and immunology, epidemiology, prevention, diagnosis, treatment, and supportive care.